Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7168 p451-455
6 October 2001

This article
Reprint
Photocopy


News summary


Adrenal insufficiency caused by inhaled corticosteroids

Health professionals should be vigilant about the possibility of adrenal insufficiency occurring in patients treated with inhaled corticosteroids, experts say. In addition, attempts should be made to reduce doses of inhaled steroids in patients with well-controlled asthma.

The recommendations follow the publication of a report of eight cases of symptomatic adrenal insufficiency in children on inhaled corticosteroid therapy (fluticasone, budesonide and beclomethasone). Dr Leena Patel, department of child health, University of Manchester, and colleagues say that two children presented with hypoglycaemia but that this did not follow sudden withdrawal of treatment or an acute illness. In the other six cases, presentation was insidious with symptoms including poor weight gain and poor height growth. The dose of inhaled corticosteroid at presentation did not exceed that recommended in step three of the British Thoracic Society guidelines in seven of the eight cases. None had received prolonged courses of systemic corticosteroids at any time. Although the daily dose of corticosteroid was not excessive in seven of the eight cases, all patients were small so the dose per area of body surface was relatively higher. “Evidence based guidelines with doses of inhaled corticosteroids recommended according to body surface area are needed,” they suggest.

The authors say that the case reports highlight the occurrence of adverse effects with doses of inhaled corticosteroids normally considered to be safe, and illustrate variations in individual sensitivity to corticosteroids. They add that since poor growth and weight gain were features of the cases, the importance of growth monitoring for all children on inhaled corticosteroids should be emphasised (Archives of Disease in Childhood 2001;85:330).

Dr George Russell, department of child health, University of Aberdeen, comments that the two cases of acute hypoglycaemia are particularly worrying because they suggest that acute adrenal insufficiency can occur even when the child is still taking the corticosteroid that caused the adrenal insufficiency in the first place.

He adds that it would be wrong to suggest a major change to established treatment that is of immense value but rather to pay more attention to stepping down treatment and being constantly vigilant about side effects (ibid, p333).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal